INTERNATIONAL PATENT: SHAPERON INC., (주)샤페론 FILES APPLICATION FOR "COMPOSITION FOR PREVENTING OR TREATING CARDIOPULMONARY BYPASS-INDUCED VASOPLEGIC SYNDROME OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT"

GENEVA, Feb. 4 -- SHAPERON INC. (606-ho Gangnam Ace Tower, 174-10 Jagok-ro,Gangnam-guSeoul 06373), (주)샤페론 (서울특별시강남구자곡로 174-10, 강남에이스타워 606호) filed a patent application (PCT/KR2024/010771) for "COMPOSITION FOR PREVENTING OR TREATING CARDIOPULMONARY BYPASS-INDUCED VASOPLEGIC SYNDROME OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT" on Jul 25, 2024. With publication no. WO/2025/023752, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application...